Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Recipient : SATT Conectus
Deal Size : Undisclosed
Deal Type : Licensing Agreement
SpikImm and SATT Conectus Sign a Agreement for Prophylactic Treatment Against the BK Virus
Details : Under the agreement, SpikImm gains worldwide exclusive licensing agreement for potent monoclonal antibodies targeting the BK virus.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
June 12, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Recipient : SATT Conectus
Deal Size : Undisclosed
Deal Type : Licensing Agreement